OBJECTIVE -To assess the levels of and the independent contributors to depressive affect and anxiety among partners of patients with type 2 diabetes.
RESEARCH DESIGN AND METHODS -The partners of 75 Latino and 113EuropeanAmerican patients with type 2 diabetes were assessed for level of depressive affect and anxiety and for three groups of potential stressors: demographics (age, gender, and education), patient disease status (time since diagnosis, HbA 1c , comorbidities, and BMI), and family stress (disease impact, spouse conflict, and family closeness). Dependent variables were partner depressive affect (Center for Epidemiological Studies-Depression scale) and anxiety (Symptom Checklist anxiety). Predictors of partner depressive affect and anxiety and partner-patient concordance rates were computed.RESULTS -Levels of depressive affect and anxiety and rates of likely depression (21.4%) were as high for partners as they were for patients. No differences were found on depressive affect or anxiety by ethnicity, but female partners scored higher than male partners on both measures. Partner-patient concordance rates were low. The family level variables accounted for the most variance in both depressive affect and anxiety, with demographics and disease status variables contributing modest or nonsignificant independent variance. CONCLUSIONS -Partners of patients with type 2 diabetes experience levels of psychological distress as high or even higher than patients, especially if the partner is female. Low levels of concordance suggest that partners can be distressed even if patients are not. Many life stresses contribute to psychological distress among partners, not just disease-related indicators. The findings suggest the utility of evaluating both partners and patients using a life-centered rather than a disease-focused perspective.
Diabetes Care 25:1564 -1570, 2002S everal reports have documented the relatively high rates of clinical and subclinical depression found among patients with diabetes (1), with major depressive disorder (MDD) alone averaging 23% among European-American patients and even higher among ethnic minority patients (2). Depression among patients with diabetes has been associated with decreased self-management, poor metabolic control, and increased risk for diabetesrelated complications (3-6).Other studies have shown that individuals who interact with depressed individuals are themselves at risk for psychological distress (7,8). Partners and patients with chronic disease often report elevated levels of anxiety and depression, frequent psychosomatic symptoms, and decreased work performance after the diagnosis and ongoing care of a patient with a chronic disease (9). Rates of MDD among the partners of patients with endstage renal disease, stroke, cardiovascular disease, chronic pain, cancer, and rheumatoid arthritis vary from 18 to 30%. Furthermore, their mean depressive symptom scores are higher than community samples, and they approach and often exceed those of patients (9 -13). Thus, the effects of c...